Building on the wide range of products available from DiaSorin for stool diagnostics, with each DiaSorin LIAISON® Ixt/Arrow™ instrument purchased during February 2014, DiaSorin is providing 2000€ ...
A next-generation multitarget stool DNA test, including assessments of DNA molecular markers and hemoglobin level, was developed to improve the performance of colorectal cancer screening, primarily ...